Related Experiment Video
Updated: Jan 19, 2026

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
Management of induction failures in newly diagnosed transplant-eligible multiple myeloma
1Division of Hematology, Mayo Clinic, Rochester, MN, USA.
No abstract available in PubMed .
Related Concept Videos
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
07:53Interphase Fluorescence in situ Hybridization of Bone Marrow Smears of Multiple Myeloma
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
05:32Multimodal Bioluminescent and Positronic-emission Tomography/Computational Tomography Imaging of Multiple Myeloma Bone Marrow Xenografts in NOG Mice
Heart Failure V: Medical Management
09:40Induction of Right Ventricular Failure by Pulmonary Artery Constriction and Evaluation of Right Ventricular Function in Mice

